News Quantified

NVAX – novavax, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Pfizer Taps Novavax Matrix-M To Refresh Vaccine Growth Story [Yahoo! Finance]

Pfizer Reshapes Portfolio With Obesity Bet, Vaccine Deal And Pricing Shift [Yahoo! Finance]

Pfizer Reshapes Portfolio With New Partnerships Oncology Push And Pricing Shifts [Yahoo! Finance]

BofA Notes Positive Interest in Novavax, Inc. (NVAX) Technology Despite Timing Concerns for Licensed Assets [Yahoo! Finance]

Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? [Seeking Alpha]

-0.8%

MISS

13.6%

BEAT

-4.4%

BEAT

-5.4%

BEAT

Form 4 NOVAVAX INC For: Jan 23 Filed by: Jacobs John C

Form 8-K NOVAVAX INC For: Jan 15

Form 8-K NOVAVAX INC For: Jan 12

Form 4 NOVAVAX INC For: Dec 11 Filed by: Casey Mark J

Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT

Top News Gainers

8/14 Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at HC Wainwright from $10.00 to $17.00. They now have a "buy" rating on the stock. 40.5%

5/13 Form 4 NOVAVAX INC For: May 13 Filed by: Glenn Gregory M 30.6%

3/17 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00. 23.9%

11/27 Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at B. Riley. They set a "buy" rating and a $12.00 price target on the stock. 21.3%

1/21 Experimental-vaccine stocks jump amid spread of new virus in China [MarketWatch] 19.6%

3/24 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial 18.8%

4/8 Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May 15.3%

2/26 Novavax Advances Development of Novel COVID-19 Vaccine 14.5%

12/31 Form S-3 NOVAVAX INC 13.7%

6/27 Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities 12.6%

Top News Decliners

3/2 Form 8-K NOVAVAX INC For: Mar 02 -28.2%

1/21 Form 424B5 NOVAVAX INC -22.9%

3/10 Epidemic response group ups coronavirus vaccine funding to $23.7 mln [Reuters] -20.5%

3/24 Novavax's stock rockets after late-stage trial for flu treatment achieves primary endpoints [MarketWatch] -18.5%

3/11 Form S-3ASR NOVAVAX INC -17.9%

3/14 Earnings Update: Novavax, Inc. Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance News] -16.3%

1/28 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -12.5%

3/25 Novavax, Inc. (NASDAQ: NVAX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -12.3%

5/8 Novavax Announces Reverse Stock Split of Common Stock -12.3%

4/21 Is This the Best Coronavirus Stock to Buy Now? [The Motley Fool] -11.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day